Diabetic Ketoacidosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency leads to decreased glucose uptake by cells, causing hyperglycemia and triggering lipolysis as an alternative energy source, resulting in free fatty acid release and hepatic conversion to ketone bodies.

• Secondary mechanism: Accumulation of ketone bodies leads to metabolic acidosis, as the body cannot adequately buffer the increased hydrogen ions, causing a drop in blood pH.

• Key complication: Severe dehydration arises due to osmotic diuresis from hyperglycemia, exacerbating electrolyte imbalances and acidosis, potentially leading to shock and organ failure if untreated.

Patient Profile

Demographics:

45-year-old female, high school teacher

History:

• Key past medical history: Type 1 Diabetes Mellitus for 20 years, Hypertension, Chronic Kidney Disease Stage 3

• Current medications: Insulin glargine, Insulin lispro, Lisinopril, Amlodipine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and difficulty breathing

• Key symptoms: Nausea, vomiting, polyuria, confusion, fruity-scented breath, fatigue

• Vital signs: Blood pressure 85/50 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, temperature 101.4°F, blood glucose 450 mg/dL, arterial blood pH 7.1

Section 1

New Complications:

As the medical team initiates treatment for the patient's diabetic ketoacidosis (DKA), including intravenous fluid rehydration and insulin therapy, a new complication arises. The patient begins to exhibit signs of acute respiratory distress, characterized by an increased respiratory rate now at 34 breaths per minute and the development of Kussmaul respirations. Despite initial insulin administration, her arterial blood pH remains critically low at 7.05, indicating persistent severe metabolic acidosis. Concurrently, laboratory results reveal an elevated serum potassium level of 6.2 mEq/L, suggesting hyperkalemia, a common but dangerous complication in DKA due to the transcellular shift of potassium in acidotic states.

The patient's renal function appears to be deteriorating rapidly, evidenced by a rising serum creatinine level, now at 3.5 mg/dL, up from baseline, and a BUN of 45 mg/dL. This exacerbates her chronic kidney disease and further complicates fluid management. The team notes decreased urine output, adding a layer of complexity to the management of her severe dehydration and electrolyte imbalances. With her blood pressure still critically low at 80/45 mmHg despite aggressive fluid resuscitation, the potential for hypovolemic shock looms large. The intersection of these complications demands urgent recalibration of her treatment plan, with consideration for potential renal replacement therapy and continuous cardiac monitoring to prevent potential arrhythmias due to electrolyte disturbances.

The patient’s altered mental status becomes more pronounced, with increasing confusion and disorientation, raising concerns about cerebral edema, especially given her rapid fluid shifts and persistent acidosis. This development necessitates a holistic reassessment of her neurological status and may require neuroimaging to rule out any intracranial complications. These emergent issues compel the healthcare team to employ advanced critical thinking and clinical judgment, balancing aggressive intervention with the risk of overcorrection, while remaining vigilant for further complications. As the team strategizes the next steps, the focus shifts towards stabilizing the patient's metabolic state, optimizing renal function, and preventing further deterioration of her condition.

Section 2

Change in Patient Status

As the medical team continues to manage the patient's complex presentation, her condition takes a sudden turn. Despite ongoing treatment, the patient’s respiratory distress intensifies, with the respiratory rate escalating to 38 breaths per minute. Her oxygen saturation begins to drop, now at 88% on room air, necessitating the initiation of supplemental oxygen. However, even with oxygen support, her saturation struggles to stabilize, suggesting a possible development of acute respiratory distress syndrome (ARDS) secondary to the severe metabolic derangement and fluid shifts. The team considers the need for non-invasive positive pressure ventilation to alleviate the work of breathing and improve oxygenation.

Simultaneously, her cardiovascular status shows signs of further decline. The patient's blood pressure remains perilously low, now at 75/40 mmHg, despite increased fluid administration. The concern for progressing into hypovolemic shock prompts the initiation of vasopressor support, starting with norepinephrine to maintain adequate perfusion. The team remains acutely aware of the risk of worsening her renal function with the vasopressors and fluid overload, which could exacerbate her potential for cerebral edema.

The patient's neurological status continues to deteriorate, with a marked decrease in her level of consciousness. She becomes increasingly lethargic and less responsive to verbal stimuli, with a Glasgow Coma Scale score dropping to 10. This alarming change prompts an urgent bedside evaluation and consideration of a CT scan to assess for any intracranial complications. The combination of persistent acidosis, potential hypoxia, and fluctuating cerebral perfusion pressures heightens the risk of neurological damage, demanding a nuanced approach to her management. The healthcare team faces the challenge of balancing aggressive resuscitative efforts while mitigating further complications, and they prepare to escalate care, including potential intubation and renal replacement therapy if necessary.

Section 3

As the healthcare team responds to the deteriorating condition of the patient, they prioritize a comprehensive reassessment to guide further intervention. A repeat arterial blood gas analysis reveals worsening metabolic acidosis, with a pH now at 7.10, a bicarbonate level of 10 mEq/L, and an elevated anion gap of 35 mEq/L, indicating persistent ketoacidosis and possible lactic acidosis due to hypoperfusion. The serum potassium level, initially elevated, has now dropped to 3.2 mEq/L following aggressive insulin therapy, raising concerns for cardiac arrhythmias. The patient's electrolytes also show a sodium level of 125 mEq/L, suggesting dilutional hyponatremia secondary to the hypotonic fluid administration.

Concurrently, a focused bedside ultrasound is performed to evaluate pulmonary and cardiac function. The exam reveals bilateral B-lines, suggestive of pulmonary edema, which supports the suspicion of acute respiratory distress syndrome (ARDS). Additionally, the echocardiogram shows a hyperdynamic left ventricle, consistent with a compensatory response to hypovolemia but raises the concern for impending cardiac dysfunction. The inferior vena cava appears collapsed, reinforcing the diagnosis of intravascular depletion, despite the risk of fluid overload.

As these findings are integrated, the clinical team decides to initiate carefully titrated hemodialysis to correct severe acidosis and manage fluid balance, while closely monitoring for signs of cerebral edema. They prepare for potential intubation due to the patient's declining mental status and respiratory failure, aiming to protect the airway and ensure adequate ventilation. This multifaceted approach highlights the complexities of managing severe diabetic ketoacidosis with concurrent ARDS and the ongoing risk of cardiovascular and neurological complications, demanding vigilant reassessment and dynamic adjustment of treatment strategies. The next steps will involve monitoring the patient's response to these interventions and readiness to address any further complications that may arise.

Section 4

As the healthcare team continues to manage the patient's condition, they observe a significant change in the patient's status. Despite the initiation of hemodialysis and close monitoring, the patient exhibits new neurological symptoms, including decreased level of consciousness and intermittent focal seizures. These developments raise the suspicion of cerebral edema, a known complication of severe diabetic ketoacidosis, particularly with rapid osmotic shifts. The team immediately conducts a CT scan of the head, which reveals subtle signs of brain swelling. This finding necessitates a delicate balance in treatment to manage the cerebral edema while avoiding exacerbation of the patient's metabolic derangements.

In response to the evolving situation, the clinical team opts to administer hypertonic saline carefully, aiming to reduce intracranial pressure without causing further electrolyte imbalances. Meanwhile, continuous EEG monitoring is initiated to assess seizure activity and guide anticonvulsant therapy. The patient's vital signs remain unstable, with persistent hypotension despite fluid resuscitation, and new-onset bradycardia is noted, complicating the cardiovascular picture. The team considers the potential need for vasopressor support, recognizing the risk of further compromising perfusion to vital organs.

These developments underscore the critical nature of the patient's condition and the high level of vigilance required to navigate the interconnected complications. The healthcare team remains poised to adjust their strategy in real-time, emphasizing the importance of multidisciplinary collaboration and advanced clinical judgment in steering the patient through this precarious phase. As the patient's journey unfolds, the focus remains on stabilizing the acute complications while anticipating and preventing secondary issues, ensuring that each intervention is aligned with the overarching goal of recovery.

Section 5

As the healthcare team continues to address the patient's critical condition, they closely monitor the response to the administration of hypertonic saline. Within hours, there is a modest improvement in neurological symptoms, evidenced by a slight increase in the patient's Glasgow Coma Scale (GCS) score from 7 to 9, indicating a cautious but positive trend toward improved consciousness. However, the EEG continues to show sporadic seizure activity, prompting the adjustment of anticonvulsant therapy with the addition of intravenous levetiracetam. This intervention requires careful titration to avoid further metabolic disturbances, as the patient's renal function remains compromised despite ongoing hemodialysis.

Concurrently, the patient's cardiovascular status demands urgent attention. The persistent hypotension, with blood pressure readings hovering around 80/50 mmHg, coupled with a heart rate declining to the mid-40s, necessitates the initiation of a norepinephrine infusion. The team carefully titrates the vasopressor to achieve a mean arterial pressure (MAP) of at least 65 mmHg, balancing the need for adequate organ perfusion against the risk of exacerbating the cerebral edema. Arterial blood gas analysis reveals a mixed metabolic acidosis with a pH of 7.22, bicarbonate level of 14 mEq/L, and a base deficit of -10, highlighting the ongoing struggle to correct the severe acid-base imbalance.

Despite these interventions, new complications arise. The patient develops oliguria, with urine output dropping to less than 20 mL/hr, raising concerns about acute kidney injury progression and potential prerenal causes given the fluid shifts and hemodynamic instability. The team considers the possibility of an evolving systemic inflammatory response syndrome (SIRS), as the patient's temperature spikes to 39.2°C, and laboratory markers indicate a rising white blood cell count of 18,000/mm³ with a left shift. These developments necessitate a careful reevaluation of the treatment strategy, underscoring the urgent need for a multidisciplinary approach to address the intertwined metabolic, neurological, and cardiovascular challenges while vigilantly monitoring for any signs of sepsis.